Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2012

01-02-2012 | Images in nephrology

“Fatal” gas in the kidney

Authors: Jsun-Liang Kao, Shih-Ching Tsai, Chih-Chung Shiao

Published in: Clinical and Experimental Nephrology | Issue 1/2012

Login to get access

Excerpt

A 56-year-old diabetic woman with 3-day history of urinary tract infection taking oral antibiotics presented with a sudden consciousness disturbance. On examination, a febrile (38.8°C) patient with a blood pressure of 83/48 mmHg and a heart rate of 120/min was seen. Laboratory studies revealed a leukocyte count of 11.0 × 109/l with band neutrophils of 22%. Urinalysis showed pyuria with 40–50 leukocytes per low-power field. Escherichia coli were found in both blood and urine cultures. The computed tomography scan disclosed massive gas collections within (arrowheads) and around (arrows) the enlarged right kidney (Fig. 1a, b), establishing the diagnosis of emphysematous pyelonephritis. Despite emergent radical nephrectomy with potent intravenous antibiotics, the patient expired due to septic shock 10 h postoperatively.
Metadata
Title
“Fatal” gas in the kidney
Authors
Jsun-Liang Kao
Shih-Ching Tsai
Chih-Chung Shiao
Publication date
01-02-2012
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2012
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0569-z

Other articles of this Issue 1/2012

Clinical and Experimental Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.